Aplenzin 348 mg/1 (Bupropion Hydrobromide TABLET, EXTENDED RELEASE) 348 mg/1

Aplenzin 348 mg is an extended-release tablet containing bupropion hydrobromide, used to aid smoking cessation and manage major depressive disorder. This medication is designed for oral administration and is manufactured by Bausch Health US, LLC.

Strength

348 mg/1

Pack Size

7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)

Manufacturer / TM Owner

Bausch Health US, LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aplenzin 348 mg is primarily used to help individuals quit smoking and to manage symptoms of major depressive disorder. Bupropion hydrobromide, the active ingredient, works by affecting certain chemicals in the brain that may be unbalanced in people with these conditions. It is important to follow the guidance of a healthcare provider when considering the use of Aplenzin for these purposes.

Side Effects

Common effects of Aplenzin 348 mg may include dry mouth, nausea, and insomnia. Some users might experience headaches or dizziness. These effects can vary from person to person, and it is advisable to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

Aplenzin 348 mg should be handled with care, especially by individuals with a history of seizures, eating disorders, or bipolar disorder. It is important to store the medication in a cool, dry place away from children and pets. Always follow the instructions provided by your healthcare provider regarding the use of this medication.

Avoid Interactions

Aplenzin 348 mg may interact with certain medications, including those that affect brain chemicals, such as antidepressants and antipsychotics. It is also advisable to avoid alcohol while taking this medication, as it can increase the risk of side effects. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

Aplenzin 348 mg is used to aid in smoking cessation and to manage symptoms of major depressive disorder.

Aplenzin 348 mg is an extended-release tablet designed for oral administration. Follow the instructions provided by your healthcare provider.

Common side effects may include dry mouth, nausea, insomnia, headaches, and dizziness.

Aplenzin 348 mg may interact with certain medications, so it is important to inform your healthcare provider about all the medications you are taking.

It is advisable to avoid alcohol while taking Aplenzin 348 mg, as it can increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.